This case was last updated from U.S. District Courts on 10/02/2023 at 07:43:08 (UTC).

AZURITY PHARMACEUTICALS, INC. et al v. ZYDUS WORLDWIDE DMCC et al

Case Summary

On 08/03/2023 AZURITY PHARMACEUTICALS, INC filed an Intellectual Property - Patent lawsuit against ZYDUS WORLDWIDE DMCC. This case was filed in U.S. District Courts, New Jersey District Court. The Judges overseeing this case are Robert Kirsch and Tonianne J. Bongiovanni. The case status is Pending - Other Pending.
Case Details Parties Documents Dockets

 

Case Details

  • Case Number:

    3:23-CV-04152

  • Filing Date:

    08/03/2023

  • Case Status:

    Pending - Other Pending

  • Case Type:

    Intellectual Property - Patent

Judge Details

Presiding Judge

Robert Kirsch

Referral Judge

Tonianne J. Bongiovanni

 

Party Details

Plaintiffs

AZURITY PHARMACEUTICALS, INC.

ARBOR PHARMACEUTICALS, LLC

TAKEDA PHARMACEUTICAL COMPANY LIMITED

Defendants

ZYDUS WORLDWIDE DMCC

ZYDUS PHARMACEUTICALS (USA) INC.

ZYDUS LIFESCIENCES LIMITED

Attorney/Law Firm Details

Plaintiff Attorneys

MARK M. MAKHAIL

CYNTHIA STENCEL BETZ

 

Court Documents

#1

(#1) COMPLAINT against ZYDUS LIFESCIENCES LIMITED, ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC ( Filing and Admin fee $ 402 receipt number ANJDC-14502416), filed by TAKEDA PHARMACEUTICAL COMPANY LIMITED, AZURITY PHARMACEUTICALS, INC., ARBOR PHARMACEUTICALS, LLC. (Attachments: #1 Exhibit A - U.S. Patent No. 9,066,936, #2 Exhibit B - U.S. Patent No. 9,169,238, #3 Exhibit C - U.S. Patent No. 9,387,249, #4 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 08/03/2023)

1 #1

Exhibit A - U.S. Patent No. 9,066,936

1 #2

Exhibit B - U.S. Patent No. 9,169,238

1 #3

Exhibit C - U.S. Patent No. 9,387,249

1 #4

Civil Cover Sheet

#2

(#2) Corporate Disclosure Statement by AZURITY PHARMACEUTICALS, INC. identifying CurtisPharma Intermediate Holdings, Inc. as Corporate Parent.. (BETZ, CYNTHIA) (Entered: 08/03/2023)

#3

(#3) Corporate Disclosure Statement by TAKEDA PHARMACEUTICAL COMPANY LIMITED. (BETZ, CYNTHIA) (Entered: 08/03/2023)

#4

(#4) Corporate Disclosure Statement by ARBOR PHARMACEUTICALS, LLC identifying Arbor Pharmaceuticals, Inc. as Corporate Parent.. (BETZ, CYNTHIA) (Entered: 08/03/2023)

#5

(#5) AO120 Patent Form filed. (jal, ) (Entered: 08/03/2023)

#6

(#6) SUMMONS ISSUED as to ZYDUS LIFESCIENCES LIMITED, ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jal, ) (Entered: 08/03/2023)

#7

(#7) NOTICE of Appearance by MARK M. MAKHAIL on behalf of ARBOR PHARMACEUTICALS, LLC, AZURITY PHARMACEUTICALS, INC., TAKEDA PHARMACEUTICAL COMPANY LIMITED (MAKHAIL, MARK) (Entered: 08/04/2023)

 

Docket Entries

08/04/2023
View Court Documents

Docket(#7) NOTICE of Appearance by MARK M. MAKHAIL on behalf of ARBOR PHARMACEUTICALS, LLC, AZURITY PHARMACEUTICALS, INC., TAKEDA PHARMACEUTICAL COMPANY LIMITED (MAKHAIL, MARK) (Entered: 08/04/2023)

[+] Read More [-] Read Less
08/03/2023
View Court Documents

Docket(#6) SUMMONS ISSUED as to ZYDUS LIFESCIENCES LIMITED, ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jal, ) (Entered: 08/03/2023)

[+] Read More [-] Read Less
08/03/2023
View Court Documents

Docket(#5) AO120 Patent Form filed. (jal, ) (Entered: 08/03/2023)

[+] Read More [-] Read Less
08/03/2023

DocketMagistrate Judge Tonianne J. Bongiovanni added. (jal, ) (Entered: 08/03/2023)

[+] Read More [-] Read Less
08/03/2023
View Court Documents

Docket(#4) Corporate Disclosure Statement by ARBOR PHARMACEUTICALS, LLC identifying Arbor Pharmaceuticals, Inc. as Corporate Parent.. (BETZ, CYNTHIA) (Entered: 08/03/2023)

[+] Read More [-] Read Less
08/03/2023
View Court Documents

Docket(#3) Corporate Disclosure Statement by TAKEDA PHARMACEUTICAL COMPANY LIMITED. (BETZ, CYNTHIA) (Entered: 08/03/2023)

[+] Read More [-] Read Less
08/03/2023
View Court Documents

Docket(#2) Corporate Disclosure Statement by AZURITY PHARMACEUTICALS, INC. identifying CurtisPharma Intermediate Holdings, Inc. as Corporate Parent.. (BETZ, CYNTHIA) (Entered: 08/03/2023)

[+] Read More [-] Read Less
08/03/2023
View Court Documents

Docket(#1) COMPLAINT against ZYDUS LIFESCIENCES LIMITED, ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC ( Filing and Admin fee $ 402 receipt number ANJDC-14502416), filed by TAKEDA PHARMACEUTICAL COMPANY LIMITED, AZURITY PHARMACEUTICALS, INC., ARBOR PHARMACEUTICALS, LLC. (Attachments: #1 Exhibit A - U.S. Patent No. 9,066,936, #2 Exhibit B - U.S. Patent No. 9,169,238, #3 Exhibit C - U.S. Patent No. 9,387,249, #4 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 08/03/2023)

[+] Read More [-] Read Less